Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – Should You Buy?

Ono Pharmaceutical Co. (OTCMKTS:OPHLF) shares gapped up prior to trading on Tuesday . The stock had previously closed at $16.10, but opened at $18.49. Ono Pharmaceutical shares last traded at $18.49, with a volume of 300 shares trading hands.

Ono Pharmaceutical Price Performance

The company has a current ratio of 3.02, a quick ratio of 2.56 and a debt-to-equity ratio of 0.10. The stock has a fifty day simple moving average of $14.24 and a two-hundred day simple moving average of $12.56. The company has a market cap of $8.68 billion, a PE ratio of 20.78 and a beta of 0.25.

Ono Pharmaceutical (OTCMKTS:OPHLF) last posted its earnings results on Monday, February 2nd. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.11. Ono Pharmaceutical had a return on equity of 7.76% and a net margin of 12.29%.The company had revenue of $892.70 million for the quarter, compared to analyst estimates of $727.58 million.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.